MyFinsight
Home
Blog
About
Dyne Therapeutics, Inc. (DYN)
Dyne Therapeutics, Inc. (DYN)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$76,971K
Free Cash flow
-$131,800K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of long-t...
Maturities of marketable securit...
Accounts payable and other liabi...
Others
Negative Cash Flow Breakdown
Net loss
Purchases of marketable securiti...
Repayments under vendor financin...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-178,556
-120,854
-111,955
-108,040
Stock-based compensation expense
14,976
13,081
11,226
11,082
Loss (gain) on sale of marketable securities
-
-
-16
0
Depreciation and amortization expense
560
550
521
528
Non-cash lease expense
90
116
35
96
Non-cash interest expense
88
79
56
60
Accretion of premium on marketable securities
-233
-271
-388
-368
Gain on sale of marketable securities
-9
-30
-
-
Loss on disposal of property and equipment
0
-30
0
0
Prepaid expenses and other current assets
-9,484
32,847
2,198
-389
Other non-current assets
-4,351
-28
-350
12,991
Accounts payable and other liabilities
18,963
-4,804
-9,463
18,470
Net cash used in operating activities
-130,286
-144,922
-111,832
-90,779
Purchases of property and equipment
1,514
221
484
395
Advance payment for long-lead equipment
-
-
0
18,790
Purchases of marketable securities
42,786
64,278
26,711
46,920
Maturities of marketable securities
24,731
33,459
18,795
28,139
Sales of marketable securities
14,774
28,648
9,382
1
Net cash (used in) provided by investing activities
-4,795
-2,392
982
-37,965
Proceeds from exercise of stock options
737
1,311
3,366
2,073
Proceeds from issuance of long-term debt, net of issuance costs paid
49,450
-
49,454
0
Proceeds from vendor financing arrangement
11,248
6,786
-
-
Repayments under vendor financing arrangement
3,325
579
-
-
Payment of debt issuance costs
0
30
9
549
Proceeds from issuance of common stock in public offering, net of issuance costs
-
-
378,154
215,803
Payment of issuance costs from public offering of common stock
0
424
-
-
Proceeds from issuance of common stock in at-the-market offering, net of issuance costs
0
0
0
0
Net cash provided by financing activities
58,110
7,064
430,965
217,327
Net (decrease) increase in cash, cash equivalents and restricted cash
-76,971
-140,250
320,115
88,583
Cash, cash equivalents and restricted cash, beginning of period
755,490
895,740
575,625
437,391
Cash, cash equivalents and restricted cash, end of period
678,519
755,490
895,740
575,625
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
long-term debt, net of...
$49,450K
(-49.95%↓ Y/Y)
Proceeds from vendor
financing arrangement
$11,248K
Proceeds from exercise of
stock options
$737K
(-71.21%↓ Y/Y)
Net cash provided by
financing activities
$58,110K
(-75.99%↓ Y/Y)
Canceled cashflow
$3,325K
Net (decrease)
increase in cash, cash...
-$76,971K
(-255.02%↓ Y/Y)
Canceled cashflow
$58,110K
Accounts payable and
other liabilities
$18,963K
(2608.33%↑ Y/Y)
Stock-based compensation
expense
$14,976K
(-36.39%↓ Y/Y)
Prepaid expenses and
other current assets
-$9,484K
(-239.32%↓ Y/Y)
Other non-current
assets
-$4,351K
Depreciation and
amortization expense
$560K
(-44.00%↓ Y/Y)
Non-cash lease expense
$90K
(181.25%↑ Y/Y)
Non-cash interest
expense
$88K
(4300.00%↑ Y/Y)
Maturities of marketable
securities
$24,731K
(-77.04%↓ Y/Y)
Sales of marketable
securities
$14,774K
(74.47%↑ Y/Y)
Repayments under vendor
financing arrangement
$3,325K
Net cash used in
operating activities
-$130,286K
(35.05%↑ Y/Y)
Canceled cashflow
$48,512K
Net cash (used in)
provided by investing...
-$4,795K
(-158.25%↓ Y/Y)
Canceled cashflow
$39,505K
Net loss
-$178,556K
(21.07%↑ Y/Y)
Accretion of premium on
marketable securities
-$233K
(78.41%↑ Y/Y)
Gain on sale of
marketable securities
-$9K
Purchases of marketable
securities
$42,786K
(-59.98%↓ Y/Y)
Purchases of property and
equipment
$1,514K
(45.44%↑ Y/Y)
Buy us a coffee